Sector portfolio · VC firm · United Kingdom
Parkwalk's Biotech portfolio
Parkwalk has backed 24 Biotech startups in rounds we track, $438M between them, shown by the stage each has reached. The best-funded is Immutrin.
24startups backed
4stages
$438Mraised between them
Series Abiggest stage
Funding by segment
- Series A$229M8
- Stage not reported$97M6
- Pre-seed and seed$45M6
- Series B$66M4
Where they are based
- United Kingdom24$438M
United KingdomFounded
2Earlier
112
113
14
115
316
517
418
19
220
121
22
23
124
125
26
2 without a founding year on record.
Total raised
- Under $1M2
- $1M to $10M9
- $10M to $50M11
- $50M to $250M2
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
22 of 24 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United Kingdom24
Startups by country, 1 country in all.
Segment by segment
Series A
8 startups · $229M raised
- IImmutrinImmutrin is a biotech developing next‐generation antibody therapies to clear amyloid deposits and reverse amyloidosis.United Kingdom$87M
- MMogrifyUnited Kingdom$50M
Fluidic AnalyticsFluidic Analytics is a biotechnology research company founded in 2013 as a spinout from the University of Cambridge.United Kingdom$28M
XamplaXampla is a materials innovation company based in Cambridge, UK, founded in 2018 as a spin-out from the University of Cambridge.United Kingdom$23M
Oxford EndovascularOxford Endovascular are developing a novel treatment for treating brain aneurysms.United Kingdom$21M
AbselionAbselion is a life science tools company based in Cambridge, UK, focused on developing measurement technologies for biomolecule analysis.United Kingdom$8.4M
CamGene TherapeuticsCamGene Therapeutics is a biotechnology company based in Cambridge, UK, focused on developing RNA-based gene medicines specificallUnited Kingdom$5.4M
Enhanc3D GenomicsEnhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.United Kingdom$5.4M
Stage not reported
6 startups · $97M raised
DIOSynVaxDIOSynVax is a clinical-stage biotechnology company based in Cambridge, UK, focused on developing next-generation vaccines using aUnited Kingdom$44M
IstessoIstesso is a London-based biopharmaceutical company focused on immunometabolism drug discovery and development.United Kingdom$29M
CarbometricsCarbometrics Ltd.United Kingdom$14M
SemarionSemarion is a University of Cambridge spin-out company founded in 2018, focused on accelerating *in vitro* drug discovery.United Kingdom$9.3M
ZentraxaZentraxa Limited is a biotechnology and engineering biology company based in Bristol, England.United Kingdom$386K
pixlbiopixlbio is a biotechnology company focused on predictive biology for drug discovery and safety assessment.United Kingdom$136K
Pre-seed and seed
6 startups · $45M raised
Scripta TherapeuticsScripta Therapeutics operates as a bio-tech company.United Kingdom$12M
IkarovecIkarovec Limited is a UK-based biotechnology company focused on developing novel bicistronic gene therapies for chronic eye diseasUnited Kingdom$10M
QkineQkine is a biotechnology company based in Cambridge, United Kingdom, founded in 2016.United Kingdom$9.9M
PharmEnablePharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.United Kingdom$7.5M
EvoralisEvoralis Limited is a biotechnology company based in Cambridge, United Kingdom, founded in May 2021.United Kingdom$4.2M
NK:IONK:IO is a London-based biotech company and a spinout from Imperial College London, focused on developing innovative therapies forUnited Kingdom$1.5M
Series B
4 startups · $66M raised
PetMedixPetMedix is a pet therapeutics startup.United Kingdom$37M
CongenicaCongenica is a biotechnology company that provides a diagnostic decision support platform.United Kingdom$15M
Sphere FluidicsSphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.United Kingdom$12M- OOxyntixOxyntix is a research-intensive team, developing and commercialising new technologies in energy and process engineering, among other fields.United Kingdom$2.6M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Parkwalk as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosPortfolio mapParkwalk portfolio map82 startups · $2.0BCo-investorsWho invests with Parkwalk34 co-investorsSector portfolioAntler's AI portfolio168 startups · $3.8BSector portfolioIndex Ventures' AI portfolio126 startups · $49BSector portfolioInnovate UK's Biotech portfolio88 startups · $1.7BSector portfolioGSR's Web3 & Crypto portfolio77 startups · $4.2B
Raising from investors like Parkwalk?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.